Management of refractory status epilepticus in adults: Still more questions than answers

The Lancet Neurology

Volumn 10, Issue 10, 2011, Pages 922-930

  Rossetti, Andrea O ^a,b   Lowenstein, Daniel H ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; ETIRACETAM; HARKOSERIDE; ISOFLURANE; KETAMINE; LIDOCAINE; LORAZEPAM; MAGNESIUM; MIDAZOLAM; PENTOBARBITAL; PHENYTOIN; PREGABALIN; PROPOFOL; THIOPENTAL; TOPIRAMATE; VALPROIC ACID; VERAPAMIL;

ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; HUMAN; INDUCED HYPOTHERMIA; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REFRACTORY STATUS EPILEPTICUS; REVIEW; SURGICAL TECHNIQUE;

EID: 80052982365     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70187-9     Document Type: Review

References (126)

1. Coeytaux A, Jallon P, Galobardes B, Morabia A Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000, 55:693-697.
2. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46:1029-1035.
3. Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001, 42:714-718. for the Status Epilepticus Study Group Hessen.
4. Lowenstein DH, Alldredge BK Status epilepticus. N Engl J Med 1998, 338:970-976.
5. Holtkamp M Treatment strategies for refractory status epilepticus. Curr Opin Crit Care 2011, 17:94-100.
6. Novy J, Logroscino G, Rossetti AO Refractory status epilepticus: a prospective observational study. Epilepsia 2010, 51:251-256.
7. Holtkamp M, Othman J, Buchheim K, Meierkord H Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005, 76:534-539.
8. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59:205-210.
9. Rossetti AO, Logroscino G, Bromfield EB Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005, 62:1698-1702.
10. Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord H A malignant variant of status epilepticus. Arch Neurol 2005, 62:1428-1431.
11. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA Short-term mortality after a first episode of status epilepticus. Epilepsia 1997, 38:1344-1349.
12. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006, 77:611-615.
13. Towne AR, Pellock JM, Ko D, DeLorenzo RJ Determinants of mortality in status epilepticus. Epilepsia 1994, 35:27-34.
14. Neligan A, Shorvon SD Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review. Epilepsy Res 2011, 93:1-10.
15. Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 2009, 50:1566-1571.
16. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol 1998, 44:908-912.
17. Adachi N, Kanemoto K, Muramatsu R, et al. Intellectual prognosis of status epilepticus in adult epilepsy patients: analysis with Wechsler Adult Intelligence Scale-revised. Epilepsia 2005, 46:1502-1509.
18. Legriel S, Azoulay E, Resche-Rigon M, et al. Functional outcome after convulsive status epilepticus. Crit Care Med 2010, 38:2295-2303.
19. Chen JW, Wasterlain CG Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006, 5:246-256.
20. Bleck TP Refractory status epilepticus. Curr Opin Crit Care 2005, 11:117-120.
21. Lowenstein DH The management of refractory status epilepticus: an update. Epilepsia 2006, 47(suppl 1):35-40.
22. Meierkord H, Holtkamp M Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 2007, 6:329-339.
23. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339:792-798.
24. Treiman DM, Walton NY, Collins JF, Point P Treatment of status epilepticus if first drug fails. Epilepsia 1999, 40(suppl 7):243.
25. Walton NY Systemic effects of generalized convulsive status epilepticus. Epilepsia 1993, 34(suppl 1):S54-S58.
26. Lothman E The biochemical basis and pathophysiology of status epilepticus. Neurology 1990, 40(suppl 2):13-23.
27. Meldrum BS, Horton RW Physiology of status epilepticus in primates. Arch Neurol 1973, 28:1-9.
28. Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 1998, 814:179-185.
29. Mazarati AM, Wasterlain CG N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett 1999, 265:187-190.
30. Kapur J, Lothman EW NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures. Epilepsy Res 1990, 5:103-111.
31. A receptors. J Neurosci 2005, 25:5511-5520.
32. Poston KL, Frucht SJ Movement disorder emergencies. J Neurol 2008, 255(suppl 4):2-13.
33. LaFrance WC Psychogenic nonepileptic seizures. Curr Opin Neurol 2008, 21:195-201.
34. Reuber M, Baker GA, Gill R, Smith DF, Chadwick DW Failure to recognize psychogenic nonepileptic seizures may cause death. Neurology 2004, 62:834-835.
35. Holtkamp M, Othman J, Buchheim K, Meierkord H Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting. Neurology 2006, 66:1727-1729.
36. Dworetzky BA, Mortati KA, Rossetti AO, Vaccaro B, Nelson A, Bromfield EB Clinical characteristics of psychogenic nonepileptic seizure status in the long-term monitoring unit. Epilepsy Behav 2006, 9:335-338.
37. Outin H, Blanc T, Vinatier I Emergency and intensive care unit management of status epilepticus in adult patients and children (new-born excluded). Société de réanimation de langue française experts recommendations. Rev Neurol (Paris) 2009, 165:297-305. (in French).
38. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010, 17:348-355. for the European Federation of Neurological Societies.
39. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001, 345:631-637.
40. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983, 249:1452-1454.
41. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 2005, 4. CD003723.
42. Aranda A, Foucart G, Ducassé JL, Grolleau S, McGonigal A, Valton L Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice. Epilepsia 2010, 51:2159-2167.
43. Shorvon S The treatment of status epilepticus. Curr Opin Neurol 2011, 24:165-170.
44. Genton P, Ferlazzo E, Thomas P Absence status epilepsy: delineation of a distinct idiopathic generalized epilepsy syndrome. Epilepsia 2008, 49:642-649.
45. Aminoff MJ Do nonconvulsive seizures damage the brain?-No. Arch Neurol 1998, 55:119-120.
46. Drislane FW Evidence against permanent neurologic damage from nonconvulsive status epilepticus. J Clin Neurophysiol 1999, 16:323-331.
47. Jordan KG, Hirsch LJ In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con. Epilepsia 2006, 47(suppl 1):41-45.
48. Kaplan PW No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: the cure may be worse than the disease). Neurophysiol Clin 2000, 30:377-382.
49. Young GB, Jordan KG Do nonconvulsive seizures damage the brain?-Yes. Arch Neurol 1998, 55:117-119.
50. Cereda C, Berger MM, Rossetti AO Bowel ischemia: a rare complication of thiopental treatment for status epilepticus. Neurocrit Care 2009, 10:355-358.
51. Rossetti AO, Logroscino G, Bromfield EB A clinical score for prognosis of status epilepticus in adults. Neurology 2006, 66:1736-1738.
52. Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 2008, 255:1561-1566.
53. Holtkamp M The anaesthetic and intensive care of status epilepticus. Curr Opin Neurol 2007, 20:188-193.
54. Rossetti AO Treatment options in the management of status epilepticus. Curr Treat Options Neurol 2010, 12:100-112.
55. Miller LC, Drislane FW Treatment of status epilepticus. Expert Rev Neurother 2008, 8:1817-1827.
56. Rossetti AO Which anesthetic should be used in the treatment of refractory status epilepticus?. Epilepsia 2007, 48(suppl 8):52-55.
57. Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 2001, 57:1036-1042.
58. Marik PE Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004, 10:3639-3649.
59. Vasile B, Rasulo F, Candiani A, Latronico N The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003, 29:1417-1425.
60. Zarovnaya EL, Jobst BC, Harris BT Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. Epilepsia 2007, 48:1002-1006.
61. Iyer VN, Hoel R, Rabinstein AA Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med 2009, 37:3024-3030.
62. Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia 2004, 45:757-763.
63. Parviainen I, Uusaro A, Kalviainen R, Mervaala E, Ruokonen E Propofol in the treatment of refractory status epilepticus. Intensive Care Med 2006, 32:1075-1079.
64. Rossetti AO, Milligan TA, Vulliémoz S, Michaelides C, Bertschi M, Lee JW A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011, 14:4-10.
65. Zhan RZ, Qi S, Wu C, Fujihara H, Taga K, Shimoji K Intravenous anesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-D-aspartate receptor inhibition. Crit Care Med 2001, 29:808-813.
66. Claassen J, Hirsch LJ, Emerson RG, Mayer SA Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43:146-153.
67. Musialowicz T, Mervaala E, Kalviainen R, Uusaro A, Ruokonen E, Parviainen I Can BIS monitoring be used to assess the depth of propofol anesthesia in the treatment of refractory status epilepticus?. Epilepsia 2010, 51:1580-1586.
68. Krishnamurthy KB, Drislane FW Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia 1999, 40:759-762.
69. Rossetti AO, Oddo M The neuro-ICU patient and electroencephalography paroxysms: if and when to treat. Curr Opin Crit Care 2010, 16:105-109.
70. Bauer G, Trinka E Nonconvulsive status epilepticus and coma. Epilepsia 2010, 51:177-190.
71. Mirsattari SM, Sharpe MD, Young GB Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004, 61:1254-1259.
72. Sheth RD, Gidal BE Refractory status epilepticus: response to ketamine. Neurology 1998, 51:1765-1766.
73. Quigg M, Nathan B, Smith T, Kapur J Effects of ketamine treatment for refractory status epilepticus. Epilepsia 2002, 43(suppl 1):282.
74. Prüss H, Holtkamp M Ketamine successfully terminates malignant status epilepticus. Epilepsy Res 2008, 82:219-222.
75. Hsieh CY, Sung PS, Tsai JJ, Huang CW Terminating prolonged refractory status epilepticus using ketamine. Clin Neuropharmacol 2010, 33:165-167.
76. Walker IA, Slovis CM Lidocaine in the treatment of status epilepticus. Acad Emerg Med 1997, 4:918-922.
77. Hamano S, Sugiyama N, Yamashita S, et al. Intravenous lidocaine for status epilepticus during childhood. Dev Med Child Neurol 2006, 48:220-222.
78. Iannetti P, Spalice A, Parisi P Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia 2005, 46:967-969.
79. Schmitt FC, Dehnicke C, Merschhemke M, Meencke HJ Verapamil attenuates the malignant treatment course in recurrent status epilepticus. Epilepsy Behav 2010, 17:565-588.
80. Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, van den Bergh WM Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J Neurol 2011, 258:218-222.
81. Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010, 51:2033-2037.
82. Wusthoff CJ, Kranick SM, Morley JF, Christina Bergqvist AG The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia 2010, 51:1083-1085.
83. Robakis TK, Hirsch LJ Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care 2006, 4:35-46.
84. Kofke WA, Young RS, Davis P, et al. Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology 1989, 71:653-659.
85. Fugate JE, Burns JD, Wijdicks EF, Warner DO, Jankowski CJ, Rabinstein AA Prolonged high-dose isoflurane for refractory status epilepticus: is it safe?. Anesth Analg 2010, 111:1520-1524.
86. Benarroch EE NMDA receptors: recent insights and clinical correlations. Neurology 2011, 76:1750-1757.
87. Ubogu EE, Sagar SM, Lerner AJ, Maddux BN, Suarez JI, Werz MA Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav 2003, 4:70-75.
88. Jevtovic-Todorovic V, Wozniak DF, Powell S, Olney JW Propofol and sodium thiopental protect against MK-801-induced neuronal necrosis in the posterior cingulate/retrosplenial cortex. Brain Res 2001, 913:185-189.
89. Martin BS, Kapur J A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia 2008, 49:248-255.
90. Towne AR, Garnett LK, Waterhouse EJ, Morton LD, DeLorenzo RJ The use of topiramate in refractory status epilepticus. Neurology 2003, 60:332-334.
91. Stojanova V, Rossetti AO Oral topiramate as an add-on treatment for refractory status epilepticus. Acta Neurol Scand 2011, published online June 29. 10.1111/j.1600-0404.2011.01562.x.
92. Novy J, Rossetti AO Oral pregabalin as an add-on treatment for status epilepticus. Epilepsia 2010, 51:2207-2210.
93. Knake S, Gruener J, Hattemer K, et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry 2008, 79:588-589.
94. Kellinghaus C, Berning S, Immisch I, et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand 2011, 123:137-141.
95. Potschka H, Fedrowitz M, Loscher W P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Neurosci Lett 2002, 327:173-176.
96. Fisher RS, Kaplan PW, Krumholz A, Lesser RP, Rosen SA, Wolff MR Failure of high-dose intravenous magnesium sulfate to control myoclonic status epilepticus. Clin Neuropharmacol 1988, 11:537-544.
97. Bodenant M, Moreau C, Sejourné C, et al. Interest of the ketogenic diet in a refractory status epilepticus in adults. Rev Neurol (Paris) 2008, 164:194-199. (in French).
98. Glaser CA, Gilliam S, Honarmand S, Tureen JH, Lowenstein DH, Anderson LJ, et al. Refractory status epilepticus in suspect encephalitis. Neurocrit Care 2008, 9:74-82.
99. Johnson N, Henry C, Fessler AJ, Dalmau J Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 2010, 75:1480-1482.
100. Maeder-Ingvar M, Prior JO, Irani SR, Rey V, Vincent A, Rossetti AO FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis. J Neurol Neurosurg Psychiatry 2010, 82:235-236.
101. Lhatoo SD, Alexopoulos AV The surgical treatment of status epilepticus. Epilepsia 2007, 48(suppl 8):61-65.
102. De Herdt V, Waterschoot L, Vonck K, et al. Vagus nerve stimulation for refractory status epilepticus. Eur J Paediatr Neurol 2009, 13:286-289.
103. Rotenberg A, Bae EH, Takeoka M, Tormos JM, Schachter SC, Pascual-Leone A Repetitive transcranial magnetic stimulation in the treatment of epilepsia partialis continua. Epilepsy Behav 2009, 14:253-257.
104. Kamel H, Cornes SB, Hegde M, Hall SE, Josephson SA Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care 2010, 12:204-210.
105. Shin HW, O'Donovan CA, Boggs JG, et al. Successful ECT treatment for medically refractory nonconvulsive status epilepticus in pediatric patient. Seizure 2011, 20:433-436.
106. Cline JS, Roos K Treatment of status epilepticus with electroconvulsive therapy. J ECT 2007, 23:30-32.
107. Corry JJ, Dhar R, Murphy T, Diringer MN Hypothermia for refractory status epilepticus. Neurocrit Care 2008, 9:189-197.
108. Miranda M, Kuester G, Ríos L, Basaez E, Hazard S Refractory nonconvulsive status epilepticus responsive to music as an add-on therapy: a second case. Epilepsy Behav 2010, 19:539-540.
109. Patwardhan RV, Dellabadia J, Rashidi M, Grier L, Nanda A Control of refractory status epilepticus precipitated by anticonvulsant withdrawal using left vagal nerve stimulation: a case report. Surg Neurol 2005, 64:170-173.
110. Winston KR, Levisohn P, Miller BR, Freeman J Vagal nerve stimulation for status epilepticus. Pediatr Neurosurg 2001, 34:190-192.
111. Misawa S, Kuwabara S, Shibuya K, Mamada K, Hattori T Low-frequency transcranial magnetic stimulation for epilepsia partialis continua due to cortical dysplasia. J Neurol Sci 2005, 234:37-39.
112. Schmitt FC, Buchheim K, Meierkord H, Holtkamp M Anticonvulsant properties of hypothermia in experimental status epilepticus. Neurobiol Dis 2006, 23:689-696.
113. Orlowski JP, Erenberg G, Lueders H, Cruse RP Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med 1984, 12:367-372.
114. Elting JW, Naalt J, Fock JM Mild hypothermia for refractory focal status epilepticus in an infant with hemimegalencephaly. Eur J Paediatr Neurol 2010, 14:452-455.
115. Holzer M Targeted temperature management for comatose survivors of cardiac arrest. N Engl J Med 2010, 363:1256-1264.
116. Cooper AD, Britton JW, Rabinstein AA Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol 2009, 66:1505-1509.
117. Costello DJ, Kilbride RD, Cole AJ Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-infectious or not?. J Neurol Sci 2009, 277:26-31.
118. Dara SI, Tungpalan LA, Manno EM, et al. Prolonged coma from refractory status epilepticus. Neurocrit Care 2006, 4:140-142.
119. Rossetti AO, Urbano LA, Delodder F, Kaplan PW, Oddo M Prognostic value of continuous EEG monitoring during therapeutic hypothermia after cardiac arrest. Crit Care 2010, 14:R173.
120. Thenayan EA, Savard M, Sharpe MD, Norton L, Young B Electroencephalogram for prognosis after cardiac arrest. J Crit Care 2010, 25:300-304.
121. Rossetti AO, Oddo M, Liaudet L, Kaplan PW Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology 2009, 72:744-749.
122. Thömke F, Weilemann SL Poor prognosis despite successful treatment of postanoxic generalized myoclonus. Neurology 2010, 74:1392-1394.
123. Koubeissi M, Alshekhlee A In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology 2007, 69:886-893.
124. Rossetti AO, Novy J, Ruffieux C, Olivier P, Foletti GB, Hayoz D, et al. Management and prognosis of status epilepticus according to hospital setting: a prospective study. Swiss Med Wkly 2009, 139:719-723.
125. Vignatelli L, Rinaldi R, Baldin E, Tinuper P, Michelucci R, Galeotti M, et al. Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts. J Neurol 2008, 255:197-204.
126. Alvarez V, Januel JM, Burnand B, Rossetti AO Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 2011, 52:1292-1296.